Skip to main content

Table 4 Laboratory abnormalities at the beginning of this hospitalization

From: Strategy to small intestine obstruction caused by Crohn’s disease on the basis of transnasal ileus tube insertion

Characteristics

Patient1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

WBC(3.69–9.16 × 109/L)

2.26

5.66

3.49

3.93

7.47

5.33

NE (2–7 × 109/L)

1.66

3.4

2.42

2.59

5.66

3.01

LY (0.8–4 × 109/L)

0.41

1.75

0.84

0.94

1.16

1.65

HGB (113–151 g/L)

97

89

88

83

105

136

PLT (101–320 × 109/L)

238

362

237

234

290

206

CRP (0–10 mg/L)

13.11

12.36

10.3

54.16

47.7

3

PCT (0.01–0.052 ng/ml)

0.1

0.05

0.34

0.09

0.05

 ≤ 0.01

PT (14–21 Sec)

12.3

12.7

14.5

24.5

12.5

17.3

ESR (0–20 mm/h)

8

5

8

12

18

9

Fecal calprotectin (0–200 µg/g)

 > 1800

 > 1800

 > 1800

 > 1800

 > 1800

 > 1800

ALB (35–55 g/L)

31.8

18

33.7

33.6

27

38.9

TBIL (3–19 µmol)

4.3

9.8

8.8

8.7

7.3

4.4

DBIL (0.5–6.8 µmol)

2.4

5.2

4.6

5.5

4.2

1.2

CHE (4230–13,000 U/L)

3969

2066

2524

2305

1985

5770

Ca (2.1–2.6 mmol/L)

1.8

1.81

2.00

2.17

2.05

2.35

Fe (5.83–34.5 µmol)

4.47

18.23

12.99

4.08

9.6

18.72

NRS2002

12

10

12

10

12

10

CDAI

498.74

518.98

511.04

485.04

515.79

401.97